The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): Updated report of a phase I study, MK3475-223.
 
Jair Bar
Honoraria - Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche/Genentech; Takeda; Vascular Biogenics
Research Funding - AstraZeneca/MedImmune (Inst); MSD (Inst); Pfizer (Inst)
 
Damien Urban
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Takeda
Consulting or Advisory Role - Merck Sharp & Dohme; Takeda; Teva
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Takeda
 
Efrat Ofek
No Relationships to Disclose
 
Aliza Ackerstein
No Relationships to Disclose
 
Ilanit Redinsky
No Relationships to Disclose
 
Nir Golan
No Relationships to Disclose
 
Iris Kamer
No Relationships to Disclose
 
David Simansky
No Relationships to Disclose
 
Amir Onn
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Speakers' Bureau - AstraZeneca; Roche
 
Stephen Raskin
Honoraria - Bristol-Myers Squibb; MSD; Novartis
 
Tiberiu Shulimzon
No Relationships to Disclose
 
Michael Peled
No Relationships to Disclose
 
Nona Zeitlin
No Relationships to Disclose
 
Sharon Halparin
No Relationships to Disclose
 
Menucha Jurkowicz
No Relationships to Disclose
 
Ramez Abukhalil
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Marina Perelman
No Relationships to Disclose
 
Alon Ben-Nun
Travel, Accommodations, Expenses - Roche